'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
about
Vascular disease in systemic lupus erythematosusImpact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysisInfluence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and SafetyAutoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice.IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study.Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patientsThe increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.Atherosclerosis in systemic lupus erythematosus.Systemic lupus erythematosus and thrombosis.Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled studyPredictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?Risk factors for coronary heart disease in connective tissue diseasesTriglyceride-Rich Lipoproteins Modulate the Distribution and Extravasation of Ly6C/Gr1(low) Monocytes.Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.Vasculitis: mechanisms involved and clinical manifestationsTraditional Chinese Medicine Decreases the Stroke Risk of Systemic Corticosteroid Treatment in Dermatitis: A Nationwide Population-Based Study.Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosusCoronary calcification in SLE: comparison with the Multi-Ethnic Study of AtherosclerosisSemiquantified noncalcified coronary plaque in systemic lupus erythematosus.17-β Estradiol reduces atherosclerosis without exacerbating lupus in ovariectomized systemic lupus erythematosus-susceptible LDLr(-/-) mice.Developments in the scientific understanding of lupus.Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.Association between depression and coronary artery calcification in women with systemic lupus erythematosusAutoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus.Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature.Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits.Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.Beyond immunosuppression - challenges in the clinical management of lupus nephritis.Intakes of vitamin B6 and dietary fiber and clinical course of systemic lupus erythematosus: a prospective study of Japanese female patients.Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study.The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?Lethal manifestations of systemic lupus erythematosus in a forensic context.Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Glucocorticoid use and abuse in SLE.
P2860
Q21285155-465D50C5-D7F8-4BB1-8EF7-4334CA5FBA50Q26750752-15418E09-6BD6-4F26-A715-3EAD0BA43F75Q33377847-F730D223-C967-4C49-9ED6-8D1F353010E7Q33425745-0C140AF6-A040-40ED-A60B-68A1B1820A7BQ33659103-970492B4-CA19-447C-AC4E-4CD1926BF5EBQ33692770-15936BDF-B9F0-47C8-8C84-6A591AB4D9D5Q34546651-94E7D239-D3C7-4950-8C1E-3BA4D85F9130Q35162593-4F9E3BE8-0193-480C-B8D7-FCA744DA5D44Q35209597-4E121423-758B-41F5-A673-313FD3537E07Q35387131-66E1726F-A6DC-4866-BF82-92BE6F41D020Q35525108-52B68456-3A0B-4245-9DEA-478EF193C5AFQ35530248-F8E61E19-3EC0-4983-90BC-FF911B57730CQ35539166-B5577075-B585-4BE2-931A-1C76E6B2597AQ35617640-AA798B84-D18B-4F74-92AD-F17FCEF2A4B0Q35639129-E3691BDA-F6E6-41FB-A7F3-FCF29E0B8F98Q35746107-906624E8-94E6-49DD-A658-319BFA0BB1D9Q35953555-4E2689B6-0265-4030-8669-26B4E02289ACQ36056947-00D639C6-7E1A-42AE-8D12-7713702B3249Q36111469-746F8175-97B3-44CF-BCD3-372CDB4E7B2FQ36126483-B3D324FD-C879-4305-89BF-52B15D2AE9D8Q36130959-B81173F4-351B-4D8B-BD7D-D5E7B8278B14Q36174352-AC8EC8F3-227B-4AAD-94FD-E21BF7C31B7EQ36277899-CDC0810B-3F4F-4EC7-A5CA-C51E12AA862BQ36468887-2FCD8147-9A1B-4ACB-B529-676BF05B7684Q36709328-8182E266-8EC0-447E-B713-7F30E6828F1CQ36746168-BB69983E-AB9B-484A-BA8C-F7A98E93E784Q36993221-9498C146-0C80-44A5-B20D-02CC793E65E0Q37033345-E9F13D8D-C82A-4340-B0CB-1483F53303D5Q37160132-4311D2CE-36CB-4CF1-92DD-0F4348CE2E37Q37174146-192621E8-79A1-4B8B-8BED-9E66BD3912D7Q37292916-9E52FA66-3A52-4D3D-9D01-42E166546381Q37335690-4B6C27F7-2945-44C0-B6E1-3D19893312EFQ37336947-63D23F05-D11F-4B95-BE54-8798586D7CB5Q37371383-BC2CD2D2-BA83-4AC8-AA62-BA0E182940A2Q37506250-0206331F-2817-491E-9E70-C2E338FFFBEFQ37690046-34A81DE5-A331-43BC-A6AC-A02C3A6E4DD0Q37817582-0DCA72D6-2B71-4CA4-BFA0-809457C76CC4Q37838467-4C049D3C-2449-45E9-A6F2-66E00F57C5DAQ37883018-8554B72A-E735-4169-9169-E369E355D927Q37978291-90777DDB-6B32-40FD-985E-61DA607E3662
P2860
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
'Not only...but also': factors ...... systemic lupus erythematosus.
@ast
'Not only...but also': factors ...... systemic lupus erythematosus.
@en
type
label
'Not only...but also': factors ...... systemic lupus erythematosus.
@ast
'Not only...but also': factors ...... systemic lupus erythematosus.
@en
prefLabel
'Not only...but also': factors ...... systemic lupus erythematosus.
@ast
'Not only...but also': factors ...... systemic lupus erythematosus.
@en
P2860
P356
P1433
P1476
'Not only...but also': factors ...... systemic lupus erythematosus.
@en
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEI142
P50
P577
2005-10-18T00:00:00Z